Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.250
+0.060 (2.74%)
Aug 14, 2025, 2:05 PM - Market open
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $10.80 million as of August 14, 2025. Its market cap has increased by 506.32% in one year.
Market Cap
10.80M
Enterprise Value
-2.67M
1-Year Change
506.32%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $42.54T to $10.80M, a decrease of -100.00%. That is a compound annual growth rate of -68.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.51M | 236.97% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | 15.55M | 146.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |